Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Microsoft (MSFT) vs Tilray Brands Inc (TLRY) Price & Performance

Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Microsoft vs Tilray Brands Inc — how do they compare? Microsoft trades at $492.62 (market cap $3.67T), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Microsoft is far larger — about 6203.5× Tilray Brands Inc's market cap, and Microsoft pays a 0.74% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

MSFTTLRY
Market Cap
$3.67T$591.60M
Volume
36,654,621
Sector
TechnologyHealth
52-Week High
$542.07$21.00
52-Week Low
$352.83$3.88
Enterprise Value
$3.65T$758.73M
Dividend Yield
0.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Microsoft

Microsoft (MSFT) trades at $493.95, down 1.15% on the day, with a bullish technical signal and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.74 exceeding expectations of $4.24. Revenue growth is steady, reaching $281.72B in 2025, supported by a net income margin of 40.31% and a high ROE of 34.04%. News highlights AI leadership and Azure momentum, though capital expenditure concerns persist.

Outlook remains positive with an 80.49% analyst buy rating and a consensus price target of $560.43, implying significant upside. Risks include competitive pressures in AI, high valuation multiples like a P/E of 27.52, and macroeconomic volatility. The stock's strength in cloud computing and consistent profitability underpins long-term growth potential.

Tilray Brands Inc

TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.

TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Microsoft

Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.

Read more on MSFT

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY